Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma

Annals of Thoracic and Cardiovascular Surgery

Volumn 14, Issue 5, 2008, Pages 319-321

  Maniwa, Yoshimasa ^a   Yoshimura, Masahiro ^b   Takata, Masahiko ^a   Nishimura, Yoshihiro ^a   Ohno, Yoshiharu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO CANCER CENTER   (Japan)

Author keywords

Chemosensitivity test; Chemotherapy; Malignant pleural mesothelioma

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; NAVELBINE; VINBLASTINE;

ARTICLE; CANCER STAGING; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FATALITY; FEMALE; HUMAN; MESOTHELIOMA; MIDDLE AGED; PALLIATIVE THERAPY; PATHOLOGY; PATIENT SELECTION; PLEURA TUMOR; TUMOR CELL CULTURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL PROLIFERATION; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FATAL OUTCOME; FEMALE; HUMANS; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; PLEURAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 58749110123     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma: A review. J Clin Oncol 1996: 14: 1007-17.
2. Ryan CW, Herndon J, Vogelzang NJ. A review of chemotherapy trials for malignant mesothelioma. Chest 1998; 113 (1 Suppl): 66-73S.
3. Steele JP, Klabatsa A. Chemotherapy options and new advances in malignant pleural mesothelioma. Ann Oncol 2005; 16: 345-51.
4. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-44.
5. Takamura Y, Kobayashi H, Taguchi T, Motomura K, Inaji H, et al. Prediction of chemotherapeutic response by collagen gel droplet embedded culturedrug sensitivity test in human breast cancers. Int J Cancer 2002: 98: 450-5.
6. Takata M, Yoshimura M, Maniwa Y, Tanaka Y, Okita Y. Chemo-sensitivity of lung cancer, difference between primary tumor and metastatic lymph node. Chest 2006; 130: 234s.
7. Nakajima K, Okita Y, Matsuda S. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction. Oncol Rep 2004: 12: 85-90.
8. Kobayashi H. Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Recent Results Cancer Res 2003, 161: 48-61.
9. Cortazar P, Johnson BE. Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 1999, 17: 1625-31.
10. Kawamura M, Gika M, Abiko T, Inoue Y, Oyama T, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol 2007, 59: 507-13.